{"id":853830,"date":"2025-05-22T11:08:03","date_gmt":"2025-05-22T15:08:03","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/renovaro-inc-announces-expedited-trail-for-2025-lawsuit-to-enforce-binding-merger-agreement-with-predictive-oncology\/"},"modified":"2025-05-22T11:08:03","modified_gmt":"2025-05-22T15:08:03","slug":"renovaro-inc-announces-expedited-trail-for-2025-lawsuit-to-enforce-binding-merger-agreement-with-predictive-oncology","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/renovaro-inc-announces-expedited-trail-for-2025-lawsuit-to-enforce-binding-merger-agreement-with-predictive-oncology\/","title":{"rendered":"Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">LOS ANGELES, May  22, 2025  (GLOBE NEWSWIRE) &#8212; <strong>Renovaro Inc. (NASDAQ: RENB),<\/strong> a TechBio leader focused on next-generation diagnostics, drug discovery, and genetically enhanced cancer therapies, today announced that it has received a ruling to expedite a trial in 2025 for the lawsuit it filed on May 9, 2025, in the Delaware Court of Chancery against Predictive Oncology Inc. (NASDAQ: POAI), seeking to enforce a binding merger agreement executed on January 1, 2025.<\/p>\n<p align=\"justify\">According to the Verified Complaint, the companies entered into a legally binding Letter Agreement pursuant to which Predictive Oncology would merge into Renovaro in exchange for a newly created class of preferred stock. Following the public disclosure of the agreement in a Form 8-K filed by POAI on January 6, 2025, POAI\u2019s stock price rose by more than 50%.<\/p>\n<p align=\"justify\">Renovaro alleges that Predictive Oncology breached the agreement\u2019s exclusivity and good faith negotiation provisions by conducting a public offering of $545,000 in securities on February 19, 2025\u2014despite contractual restrictions\u2014and later attempting to terminate the agreement unilaterally on April 3, 2025, without engaging meaningfully in the negotiation of a definitive merger agreement.<\/p>\n<p align=\"justify\">\u201cThis transaction was intended to create strategic and shareholder value for both companies. Unfortunately, Predictive Oncology has disregarded its contractual commitments,\u201d said a Renovaro spokesperson. \u201cWe are pursuing legal remedies to enforce our rights and protect our shareholders\u2019 interests.\u201d<\/p>\n<p align=\"justify\">The litigation seeks specific performance, injunctive relief, and damages for the alleged breaches. The case is pending in the Delaware Court of Chancery under Case No. 2025-0509.<\/p>\n<p align=\"justify\">\n        <strong>About Renovaro Inc.<\/strong>\n      <\/p>\n<p align=\"justify\">Renovaro\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=lC2AFX1HMKxEIeT_1RvXbT1TyZJ5EeoIED_yglJFYmvvGrJNjOfU_7d9mmYFXDAnWTDONhm29dFljREp1tfLN86-VXAO5gRJHAU_-es2IKPmYELCNFOfao9b5F8ODywpIKuVCRx-CRXDzS0pu4TaeDUfjeLzhyc89WQb-8HUvfY9YXYJyg0ikNHLa9AS8jbnbSXc9EzaI92aMI0ITsaqeUGwrsYKzgT4kErCpS3u7hZwIYRZTo87dOJHrSt0AoCg2ip6gA4n-c1Jr2IoHnjUdhAPIfcWRpSYAgfnxrdwRNcnLn-FeWQMaVe2azHPIFnBT0bN1DHgSdi7CTo6nxRkal3NGHVRaneBxjsi4Nm0Ij4bassoA3KqE6cWVwm23w6tBRI35mrqJ-ByLIREiqypthY2W_URrVbru-29S4jQpX--wviYEH2zUlxLI1CpExER9nVajJ4JiVXrjGMihRwb4Si7dgq7gG_U3QGBwCyBXeoh2eVaQB0sXu5ljP1eMnH6\" rel=\"nofollow\" target=\"_blank\">https:\/\/renovarogroup.com\/<\/a>\u00a0aims to accelerate precision and personalized medicine for longevity powered by mutually reinforcing AI and biotechnology platforms for early diagnosis, better-targeted treatments, and drug discovery. Renovaro Inc. includes RenovaroBio with its advanced cell-gene immunotherapy company and RenovaroCube that is leveraging AI for multi-omic diagnostics and drug development, and BioSymetrics which specializes in contingent AI for precision neurology. For more information, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ZM57KSqOacSe-Zvx1veG5FuU96pZ55uC3dNdOcB3A_gCElO3giw1vMi9-u3515F6K-OmNu_ay20d2i06chhy64tvD18yx6ViVcLVQBX_FrEJm72W1W-PBGzH2qEzU4WvD2XeSy136Zp2X8jdBIjqqZNMuED41mjzKCeYt6FIl6ka2ooKDWvHruql3rf-nEgQWeJTFNu4FzVOXRc5SIg8lOXOLhOlDqs7lqqMTzIoAE2c26sMG1K0crhT8MeJrlfyKA_bC01Y1tYD1m5dd2aLmA==\" rel=\"nofollow\" target=\"_blank\">www.renovarogroup.com<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>Forward-Looking Statements<\/strong>\n      <\/p>\n<p align=\"justify\">This release contains forward-looking statements, including those relating to the pending litigation and the proposed merger. These statements involve risks and uncertainties and are subject to change based on future developments. Renovaro undertakes no obligation to update any forward-looking statements except as required by law.<\/p>\n<p>\n        <strong>Investor Relations<\/strong>\n      <\/p>\n<p>Chris Tyson<br \/>Executive Vice President<br \/>MZ Group &#8211; MZ North America<br \/>949-491-8235<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=oeD9qeR5H2FI2mV9S2P6BJqrWdyiDQS75j0w_PP0Ps9nfi78q56ig5fWj_NCb6lolyAt3YkXPUVIen0eFJjIxBmUk_zL2m0uGPy6r70sOeNYo6ad9EBZvUxOmvv_ThMXXY8grR5LAGYNDeXpeluSkWXWXzOZKL6UaPt4g4SRYD5hKRcUpuK1qlcab0RU_iNO0Z-E7dHPRCKn09tTGLFJA0DIZ7TBclL95ITLYgrUjks=\" rel=\"nofollow\" target=\"_blank\">RENB@mzgroup.us<\/a><br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VGxLbjePc9nBXFHDH86NOwV_99HT7GCZMHuV8RPIRY9qFq_Jt_0cqnlWJA9alHB432QmavhWfCGiGmWJGPzSgQ3-0EH9kZFAqi8rf1QB0TCbDI9Oe7lYP3_MhgOMcR56Q5IXfVapECTGsOuxQAfjSvsWb8-KWd885rCgyLfSGedcr-NDga14e30x-DbPADthklBf31k8U43APoe916izhdm6lPnSdiOIsLHC-eftcro=\" rel=\"nofollow\" target=\"_blank\">www.mzgroup.us<\/a><\/p>\n<p>\n        <strong>For media inquiries, please contact:<\/strong>\n      <\/p>\n<p>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=IBW1AjtA4TXWVZPilxOyfckwYf3qetsFsgsRPCLUBQ0rFLKnYpZTgOJqDzLxobNzfauCaQ1D1Z1jV55rpETyNbXHVey-GL86hN1w4GtjHjc=\" rel=\"nofollow\" target=\"_blank\">karen@renovarocube.com<\/a>\n      <\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ1NjYzOCM2OTU2NDI1IzIxMjA2Nzk=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NDI2YjI0NGQtMWVlYi00ZTUyLWJmOGItNTI3YmU0NTQ2M2RjLTExMzIyNTAtMjAyNS0wNS0yMi1lbg==\/tiny\/Renovaro-Inc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>LOS ANGELES, May 22, 2025 (GLOBE NEWSWIRE) &#8212; Renovaro Inc. (NASDAQ: RENB), a TechBio leader focused on next-generation diagnostics, drug discovery, and genetically enhanced cancer therapies, today announced that it has received a ruling to expedite a trial in 2025 for the lawsuit it filed on May 9, 2025, in the Delaware Court of Chancery against Predictive Oncology Inc. (NASDAQ: POAI), seeking to enforce a binding merger agreement executed on January 1, 2025. According to the Verified Complaint, the companies entered into a legally binding Letter Agreement pursuant to which Predictive Oncology would merge into Renovaro in exchange for a newly created class of preferred stock. Following the public disclosure of the agreement in a Form 8-K filed by POAI &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/renovaro-inc-announces-expedited-trail-for-2025-lawsuit-to-enforce-binding-merger-agreement-with-predictive-oncology\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-853830","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/renovaro-inc-announces-expedited-trail-for-2025-lawsuit-to-enforce-binding-merger-agreement-with-predictive-oncology\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"LOS ANGELES, May 22, 2025 (GLOBE NEWSWIRE) &#8212; Renovaro Inc. (NASDAQ: RENB), a TechBio leader focused on next-generation diagnostics, drug discovery, and genetically enhanced cancer therapies, today announced that it has received a ruling to expedite a trial in 2025 for the lawsuit it filed on May 9, 2025, in the Delaware Court of Chancery against Predictive Oncology Inc. (NASDAQ: POAI), seeking to enforce a binding merger agreement executed on January 1, 2025. According to the Verified Complaint, the companies entered into a legally binding Letter Agreement pursuant to which Predictive Oncology would merge into Renovaro in exchange for a newly created class of preferred stock. Following the public disclosure of the agreement in a Form 8-K filed by POAI &hellip; Continue reading &quot;Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/renovaro-inc-announces-expedited-trail-for-2025-lawsuit-to-enforce-binding-merger-agreement-with-predictive-oncology\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-22T15:08:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ1NjYzOCM2OTU2NDI1IzIxMjA2Nzk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renovaro-inc-announces-expedited-trail-for-2025-lawsuit-to-enforce-binding-merger-agreement-with-predictive-oncology\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renovaro-inc-announces-expedited-trail-for-2025-lawsuit-to-enforce-binding-merger-agreement-with-predictive-oncology\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology\",\"datePublished\":\"2025-05-22T15:08:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renovaro-inc-announces-expedited-trail-for-2025-lawsuit-to-enforce-binding-merger-agreement-with-predictive-oncology\\\/\"},\"wordCount\":398,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renovaro-inc-announces-expedited-trail-for-2025-lawsuit-to-enforce-binding-merger-agreement-with-predictive-oncology\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ1NjYzOCM2OTU2NDI1IzIxMjA2Nzk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renovaro-inc-announces-expedited-trail-for-2025-lawsuit-to-enforce-binding-merger-agreement-with-predictive-oncology\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renovaro-inc-announces-expedited-trail-for-2025-lawsuit-to-enforce-binding-merger-agreement-with-predictive-oncology\\\/\",\"name\":\"Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renovaro-inc-announces-expedited-trail-for-2025-lawsuit-to-enforce-binding-merger-agreement-with-predictive-oncology\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renovaro-inc-announces-expedited-trail-for-2025-lawsuit-to-enforce-binding-merger-agreement-with-predictive-oncology\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ1NjYzOCM2OTU2NDI1IzIxMjA2Nzk=\",\"datePublished\":\"2025-05-22T15:08:03+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renovaro-inc-announces-expedited-trail-for-2025-lawsuit-to-enforce-binding-merger-agreement-with-predictive-oncology\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renovaro-inc-announces-expedited-trail-for-2025-lawsuit-to-enforce-binding-merger-agreement-with-predictive-oncology\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renovaro-inc-announces-expedited-trail-for-2025-lawsuit-to-enforce-binding-merger-agreement-with-predictive-oncology\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ1NjYzOCM2OTU2NDI1IzIxMjA2Nzk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ1NjYzOCM2OTU2NDI1IzIxMjA2Nzk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renovaro-inc-announces-expedited-trail-for-2025-lawsuit-to-enforce-binding-merger-agreement-with-predictive-oncology\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/renovaro-inc-announces-expedited-trail-for-2025-lawsuit-to-enforce-binding-merger-agreement-with-predictive-oncology\/","og_locale":"en_US","og_type":"article","og_title":"Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology - Market Newsdesk","og_description":"LOS ANGELES, May 22, 2025 (GLOBE NEWSWIRE) &#8212; Renovaro Inc. (NASDAQ: RENB), a TechBio leader focused on next-generation diagnostics, drug discovery, and genetically enhanced cancer therapies, today announced that it has received a ruling to expedite a trial in 2025 for the lawsuit it filed on May 9, 2025, in the Delaware Court of Chancery against Predictive Oncology Inc. (NASDAQ: POAI), seeking to enforce a binding merger agreement executed on January 1, 2025. According to the Verified Complaint, the companies entered into a legally binding Letter Agreement pursuant to which Predictive Oncology would merge into Renovaro in exchange for a newly created class of preferred stock. Following the public disclosure of the agreement in a Form 8-K filed by POAI &hellip; Continue reading \"Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/renovaro-inc-announces-expedited-trail-for-2025-lawsuit-to-enforce-binding-merger-agreement-with-predictive-oncology\/","og_site_name":"Market Newsdesk","article_published_time":"2025-05-22T15:08:03+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ1NjYzOCM2OTU2NDI1IzIxMjA2Nzk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renovaro-inc-announces-expedited-trail-for-2025-lawsuit-to-enforce-binding-merger-agreement-with-predictive-oncology\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renovaro-inc-announces-expedited-trail-for-2025-lawsuit-to-enforce-binding-merger-agreement-with-predictive-oncology\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology","datePublished":"2025-05-22T15:08:03+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renovaro-inc-announces-expedited-trail-for-2025-lawsuit-to-enforce-binding-merger-agreement-with-predictive-oncology\/"},"wordCount":398,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renovaro-inc-announces-expedited-trail-for-2025-lawsuit-to-enforce-binding-merger-agreement-with-predictive-oncology\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ1NjYzOCM2OTU2NDI1IzIxMjA2Nzk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renovaro-inc-announces-expedited-trail-for-2025-lawsuit-to-enforce-binding-merger-agreement-with-predictive-oncology\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/renovaro-inc-announces-expedited-trail-for-2025-lawsuit-to-enforce-binding-merger-agreement-with-predictive-oncology\/","name":"Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renovaro-inc-announces-expedited-trail-for-2025-lawsuit-to-enforce-binding-merger-agreement-with-predictive-oncology\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renovaro-inc-announces-expedited-trail-for-2025-lawsuit-to-enforce-binding-merger-agreement-with-predictive-oncology\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ1NjYzOCM2OTU2NDI1IzIxMjA2Nzk=","datePublished":"2025-05-22T15:08:03+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renovaro-inc-announces-expedited-trail-for-2025-lawsuit-to-enforce-binding-merger-agreement-with-predictive-oncology\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/renovaro-inc-announces-expedited-trail-for-2025-lawsuit-to-enforce-binding-merger-agreement-with-predictive-oncology\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renovaro-inc-announces-expedited-trail-for-2025-lawsuit-to-enforce-binding-merger-agreement-with-predictive-oncology\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ1NjYzOCM2OTU2NDI1IzIxMjA2Nzk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ1NjYzOCM2OTU2NDI1IzIxMjA2Nzk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renovaro-inc-announces-expedited-trail-for-2025-lawsuit-to-enforce-binding-merger-agreement-with-predictive-oncology\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/853830","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=853830"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/853830\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=853830"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=853830"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=853830"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}